News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|March 25, 2022

Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Author(s)Miranda Hester

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA restricts sale of unapproved ingestible fluoride drugs for children | image credit: Contemporary Pediatrics

FDA restricts sale of unapproved ingestible fluoride drugs for children

ByMorgan Ebert, Managing Editor

October 31st 2025

FDA accepts pegvaliase-pqpz sBLA to expand treatment to patients with PKU aged 12-17 years | Image credit: Contemporary Pediatrics

FDA accepts pegvaliase-pqpz sBLA to expand treatment to patients with PKU aged 12-17 years

ByJoshua Fitch, Senior Editor

October 29th 2025

Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks | Image Credit: © Liga Cerina - © Liga Cerina - stock.adobe.com.

Upadacitinib achieves 50% reduction in Total Vitiligo Area Scoring Index at 48 weeks

ByJoshua Fitch, Senior Editor

October 29th 2025

Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata | Image Credit: © Alex Papp - © Alex Papp - stock.adobe.com.

Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata

ByJoshua Fitch, Senior Editor

October 24th 2025

FDA issues CRL for SYD-101 to treat progression of pediatric myopia | Image credit: Contemporary Pediatrics

FDA issues CRL for SYD-101 to treat progression of pediatric myopia

ByJoshua Fitch, Senior Editor

October 24th 2025

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

AAP does not recommend routine use of leucovorin in children with autism

FDA restricts sale of unapproved ingestible fluoride drugs for children

Novel therapies for type 1 diabetes

Jill Blumenthal, MD, highlights PURPOSE 2 data of lenacapavir and gender-affirming hormone therapy

Anne Kasmar, MD, MSc, on advancing innovation and collaboration in antimicrobial resistance

© 2025 MJH Life Sciences^®

All rights reserved.